PARAG PATEL: Open Payments
NPI 1689751646 · HAMMONTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,998 in 205 payments from 33 companies in 2025. Trend: 2023 $3,114 · 2024 $3,366 · 2025 $3,998
Food & beverage: $3,998
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 23 | $430 |
| ABBVIE INC. | 27 | $424 |
| AstraZeneca Pharmaceuticals LP | 18 | $379 |
| Boston Scientific Corporation | 3 | $291 |
| Abbott Laboratories | 7 | $266 |
| ABIOMED | 6 | $246 |
| Otsuka America Pharmaceutical, Inc. | 12 | $219 |
| PFIZER INC. | 13 | $184 |
| Amgen Inc. | 12 | $180 |
| GlaxoSmithKline, LLC. | 12 | $152 |
Products named: REXULTI, WATCHMAN FLX, VRAYLAR, FREESTYLE LIBRE 3, Ozempic, FARXIGA, AIRSUPRA, TRELEGY ELLIPTA.
Industry payments across NJ — which companies pay providers there.
